Literature DB >> 1617767

Expression and localization of dystrophin in human cardiac Purkinje fibers.

R D Bies1, D Friedman, R Roberts, M B Perryman, C T Caskey.   

Abstract

BACKGROUND: Mutations in the dystrophin gene produce clinical manifestations of disease in heart, brain, and skeletal muscle in patients with Duchenne and Beckers muscular dystrophy (DMD/BMD). Conduction disturbances and heart block contribute to cardiac decompensation in these patients, which suggests an important role for dystrophia in the cardiac conduction system. We therefore examined the messenger RNA (mRNA) expression and protein localization of dystrophin in normal human cardiac Purkinje fibers. METHODS AND
RESULTS: Polymerase chain reaction amplification of isolated Purkinje fiber complementary DNA identified several alternatively spliced mRNA transcripts encoding for carboxy-terminal isoforms of the dystrophin protein. The predominant mRNA transcript detected was a splice form previously detected in the brain. Antipeptide antibodies specific for a carboxy-terminal dystrophin sequence were used for Western blot analysis and immunocytochemical localization. These antisera detect approximately 400,000-d immunoreactive band or bands on Western blot in normal heart and Purkinje fibers but not in DMD heart. Immunocytochemical staining showed that dystrophin was localized to the membrane surface of the Purkinje fiber.
CONCLUSIONS: These results suggest that dystrophin may be an important molecule for membrane function in the Purkinje conduction system of the heart and support the hypothesis that defective dystrophin expression contributes to the cardiac conduction disturbances seen in DMD/BMD:

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1617767     DOI: 10.1161/01.cir.86.1.147

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

1.  An intact cysteine-rich domain is required for dystrophin function.

Authors:  R D Bies; C T Caskey; R Fenwick
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  Complete AV block and cardiac syncope in a patient with Duchenne muscular dystrophy.

Authors:  Refik Emre Altekin; Atakan Yanikoglu; Mustafa Ucar; Cengiz Ermis
Journal:  J Cardiol Cases       Date:  2011-02-16

3.  Molecular biology of heart disease.

Authors:  Robert Roberts
Journal:  World J Cardiol       Date:  2011-04-26

4.  Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins.

Authors:  S H Gee; R Madhavan; S R Levinson; J H Caldwell; R Sealock; S C Froehner
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

5.  Genetic predisposition to cardiomyopathies.

Authors:  R Abdulla
Journal:  Pediatr Cardiol       Date:  1997 Jul-Aug       Impact factor: 1.655

Review 6.  The dystrophin superfamily: variability and complexity.

Authors:  E Fabbrizio; F Pons; A Robert; G Hugon; A Bonet-Kerrache; D Mornet
Journal:  J Muscle Res Cell Motil       Date:  1994-12       Impact factor: 2.698

Review 7.  Molecular basis of hypertrophic and dilated cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  Tex Heart Inst J       Date:  1994

8.  Dystrophin predominantly localizes to the transverse tubule/Z-line regions of single ventricular myocytes and exhibits distinct associations with the membrane.

Authors:  V Peri; B Ajdukovic; P Holland; B S Tuana
Journal:  Mol Cell Biochem       Date:  1994-01-12       Impact factor: 3.396

9.  The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5' X-linked dilated cardiomyopathy.

Authors:  Marcella Neri; Emanuele Valli; Giovanna Alfano; Matteo Bovolenta; Pietro Spitali; Claudio Rapezzi; Francesco Muntoni; Sandro Banfi; Giovanni Perini; Francesca Gualandi; Alessandra Ferlini
Journal:  BMC Med Genet       Date:  2012-03-28       Impact factor: 2.103

10.  A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart.

Authors:  F Muntoni; L Wilson; G Marrosu; M G Marrosu; C Cianchetti; L Mestroni; A Ganau; V Dubowitz; C Sewry
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.